{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:21:32Z","timestamp":1773800492881,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2017-88908-R"],"award-info":[{"award-number":["SAF2017-88908-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PT17\/0009\/0006"],"award-info":[{"award-number":["PT17\/0009\/0006"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["COV20\/00788"],"award-info":[{"award-number":["COV20\/00788"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["ACCI2018\/29"],"award-info":[{"award-number":["ACCI2018\/29"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011264","name":"FP7 People: Marie-Curie Actions","doi-asserted-by":"publisher","award":["813533"],"award-info":[{"award-number":["813533"]}],"id":[{"id":"10.13039\/100011264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioData Mining"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Here we present a web interface that implements a comprehensive mechanistic model of the SARS-CoV-2 disease map. In this framework, the detailed activity of the human signaling circuits related to the viral infection, covering from the entry and replication mechanisms to the downstream consequences as inflammation and antigenic response, can be inferred from gene expression experiments. Moreover, the effect of potential interventions, such as knock-downs, or drug effects (currently the system models the effect of more than 8000 DrugBank drugs) can be studied. This freely available tool not only provides an unprecedentedly detailed view of the mechanisms of viral invasion and the consequences in the cell but has also the potential of becoming an invaluable asset in the search for efficient antiviral treatments.<\/jats:p>","DOI":"10.1186\/s13040-021-00234-1","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T01:03:18Z","timestamp":1611190998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mechanistic modeling of the SARS-CoV-2 disease map"],"prefix":"10.1186","volume":"14","author":[{"given":"Kinza","family":"Rian","sequence":"first","affiliation":[]},{"given":"Marina","family":"Esteban-Medina","sequence":"additional","affiliation":[]},{"given":"Marta R.","family":"Hidalgo","sequence":"additional","affiliation":[]},{"given":"Cankut","family":"\u00c7ubuk","sequence":"additional","affiliation":[]},{"given":"Matias M.","family":"Falco","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Loucera","sequence":"additional","affiliation":[]},{"given":"Devrim","family":"Gunyel","sequence":"additional","affiliation":[]},{"given":"Marek","family":"Ostaszewski","sequence":"additional","affiliation":[]},{"given":"Mar\u00eda","family":"Pe\u00f1a-Chilet","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3318-120X","authenticated-orcid":false,"given":"Joaqu\u00edn","family":"Dopazo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"issue":"10223","key":"234_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"395","author":"C Wang","year":"2020","unstructured":"Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470\u20133.","journal-title":"Lancet"},{"issue":"2","key":"234_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/bib\/bby024","volume":"20","author":"M Ostaszewski","year":"2019","unstructured":"Ostaszewski M, Gebel S, Kuperstein I, Mazein A, Zinovyev A, Dogrusoz U, et al. Community-driven roadmap for integrated disease maps. Briefings Bioinformatics. 2019;20(2):659\u201370.","journal-title":"Briefings Bioinformatics"},{"issue":"7816","key":"234_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459\u201368.","journal-title":"Nature"},{"issue":"1","key":"234_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41597-020-0477-8","volume":"7","author":"M Ostaszewski","year":"2020","unstructured":"Ostaszewski M, Mazein A, Gillespie ME, Kuperstein I, Niarakis A, Hermjakob H, et al. COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms. Scientific Data. 2020;7(1):136.","journal-title":"Scientific Data"},{"issue":"1","key":"234_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41540-018-0059-y","volume":"4","author":"A Mazein","year":"2018","unstructured":"Mazein A, Ostaszewski M, Kuperstein I, Watterson S, Le Nov\u00e8re N, Lefaudeux D, et al. Systems medicine disease maps: community-driven comprehensive representation of disease mechanisms. npj Systems Biol Applications. 2018;4(1):21.","journal-title":"npj Systems Biol Applications"},{"issue":"2","key":"234_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cels.2016.02.003","volume":"2","author":"MK Yu","year":"2016","unstructured":"Yu MK, Kramer M, Dutkowski J, Srivas R, Licon K, Kreisberg JF, et al. Translation of genotype to phenotype by a hierarchy of cell subsystems. Cell Systems. 2016;2(2):77\u201388.","journal-title":"Cell Systems"},{"issue":"3","key":"234_CR7","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.18632\/oncotarget.14107","volume":"8","author":"MR Hidalgo","year":"2017","unstructured":"Hidalgo MR, Cubuk C, Amadoz A, Salavert F, Carbonell-Caballero J, Dopazo J. High throughput estimation of functional cell activities reveals disease mechanisms and predicts relevant clinical outcomes. Oncotarget. 2017;8(3):5160\u201378.","journal-title":"Oncotarget"},{"issue":"1","key":"234_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41540-019-0087-2","volume":"5","author":"C \u00c7ubuk","year":"2019","unstructured":"\u00c7ubuk C, Hidalgo MR, Amadoz A, Rian K, Salavert F, Pujana MA, et al. Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models. NPJ Systems Biology. 2019;5(1):7.","journal-title":"NPJ Systems Biology"},{"issue":"21","key":"234_CR9","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1158\/0008-5472.CAN-17-2705","volume":"78","author":"C Cubuk","year":"2018","unstructured":"Cubuk C, Hidalgo MR, Amadoz A, Pujana MA, Mateo F, Herranz C, et al. Gene expression integration into pathway modules reveals a pan-cancer metabolic landscape. Cancer Research. 2018;78(21):6059\u201372.","journal-title":"Cancer Research"},{"issue":"408","key":"234_CR10","doi-asserted-by":"publisher","first-page":"ra130","DOI":"10.1126\/scisignal.aab0990","volume":"8","author":"D Fey","year":"2015","unstructured":"Fey D, Halasz M, Dreidax D, Kennedy SP, Hastings JF, Rauch N, et al. Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients. Sci Signal. 2015;8(408):ra130.","journal-title":"Sci Signal"},{"issue":"1","key":"234_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13062-018-0219-4","volume":"13","author":"MR Hidalgo","year":"2018","unstructured":"Hidalgo MR, Amadoz A, Cubuk C, Carbonell-Caballero J, Dopazo J. Models of cell signaling uncover molecular mechanisms of high-risk neuroblastoma and predict disease outcome. Biology Direct. 2018;13(1):16.","journal-title":"Biology Direct."},{"issue":"3","key":"234_CR12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/bjd.17698","volume":"181","author":"E Chac\u00f3n-Solano","year":"2019","unstructured":"Chac\u00f3n-Solano E, Le\u00f3n C, D\u00edaz F, Garc\u00eda-Garc\u00eda F, Garc\u00eda M, Esc\u00e1mez M, et al. Fibroblasts activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatoses. J British Journal of Dermatology. 2019;181(3):512\u201322.","journal-title":"J British Journal of Dermatology"},{"issue":"1","key":"234_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-55454-7","volume":"9","author":"M Pe\u00f1a-Chilet","year":"2019","unstructured":"Pe\u00f1a-Chilet M, Esteban-Medina M, Falco MM, Rian K, Hidalgo MR, Loucera C, et al. Using mechanistic models for the clinical interpretation of complex genomic variation. Scientific Reports. 2019;9(1):1\u201312.","journal-title":"Scientific Reports"},{"key":"234_CR14","doi-asserted-by":"publisher","first-page":"18494","DOI":"10.1038\/srep18494","volume":"5","author":"A Amadoz","year":"2015","unstructured":"Amadoz A, Sebastian-Leon P, Vidal E, Salavert F, Dopazo J. Using activation status of signaling pathways as mechanism-based biomarkers to predict drug sensitivity. Scientific Reports. 2015;5:18494.","journal-title":"Scientific Reports"},{"key":"234_CR15","doi-asserted-by":"crossref","unstructured":"Falco MM, Pe\u00f1a-Chilet M, Loucera C, Hidalgo MR, Dopazo J. Mechanistic models of signaling pathways deconvolute the glioblastoma single-cell functional landscape. NAR Cancer. 2020;2(2):zcaa011.","DOI":"10.1093\/narcan\/zcaa011"},{"key":"234_CR16","doi-asserted-by":"crossref","unstructured":"Saez-Rodriguez J, Bl\u00fcthgen N. Personalized signaling models for personalized treatments. Molecular Systems Biology. 2020;16(1):e9042.","DOI":"10.15252\/msb.20199042"},{"key":"234_CR17","doi-asserted-by":"crossref","unstructured":"Hastings JF, O'Donnell Y, Fey D, Croucher DR. Applications of personalised signalling network models in precision oncology. Pharmacology Therapeutics. 2020;212:107555.","DOI":"10.1016\/j.pharmthera.2020.107555"},{"issue":"1","key":"234_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.molmet.2015.10.005","volume":"5","author":"M Razzoli","year":"2016","unstructured":"Razzoli M, Frontini A, Gurney A, Mondini E, Cubuk C, Katz LS, et al. Stress-induced activation of brown adipose tissue prevents obesity in conditions of low adaptive thermogenesis. Molecular Metabolism. 2016;5(1):19\u201333.","journal-title":"Molecular Metabolism"},{"key":"234_CR19","doi-asserted-by":"crossref","unstructured":"Ferreira PG, Mu\u00f1oz-Aguirre M, Reverter F, CPS G, Sousa A, Amadoz A, et al. The effects of death and post-mortem cold ischemia on human tissue transcriptomes. Nature Communications. 2018, 9(1):490.","DOI":"10.1038\/s41467-017-02772-x"},{"issue":"W1","key":"234_CR20","doi-asserted-by":"publisher","first-page":"W270","DOI":"10.1093\/nar\/gkv349","volume":"43","author":"RD Hernansaiz-Ballesteros","year":"2015","unstructured":"Hernansaiz-Ballesteros RD, Salavert F, Sebastian-Leon P, Aleman A, Medina I, Dopazo J. Assessing the impact of mutations found in next generation sequencing data over human signaling pathways. Nucleic Acids Res. 2015;43(W1):W270\u20135.","journal-title":"Nucleic Acids Res"},{"key":"234_CR21","doi-asserted-by":"crossref","unstructured":"Salavert F, Hidalgo MR, Amadoz A, Cubuk C, Medina I, Crespo D, et al. Actionable pathways: interactive discovery of therapeutic targets using signaling pathway models, Nucleic Acids Res. 2016;44(W1):W212\u20136.","DOI":"10.1093\/nar\/gkw369"},{"issue":"1","key":"234_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12859-019-2969-0","volume":"20","author":"M Esteban-Medina","year":"2019","unstructured":"Esteban-Medina M, Pe\u00f1a-Chilet M, Loucera C, Dopazo J. Exploring the druggable space around the Fanconi anemia pathway using machine learning and mechanistic models. BMC Bioinformatics. 2019;20(1):370.","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"234_CR23","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2015","unstructured":"Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Research. 2015;44(D1):D457\u2013D62.","journal-title":"Nucleic Acids Research"},{"key":"234_CR24","doi-asserted-by":"crossref","unstructured":"UniProt_Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic acids research. 2018;47(D1):D506\u2013D15.","DOI":"10.1093\/nar\/gky1049"},{"issue":"5","key":"234_CR25","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/bib\/bby040","volume":"20","author":"A Amadoz","year":"2019","unstructured":"Amadoz A, Hidalgo MR, \u00c7ubuk C, Carbonell-Caballero J, Dopazo J. A comparison of mechanistic signaling pathway activity analysis methods. Briefings Bioinformatics. 2019;20(5):1655\u201368.","journal-title":"Briefings Bioinformatics"},{"issue":"12","key":"234_CR26","doi-asserted-by":"publisher","first-page":"e1000591","DOI":"10.1371\/journal.pcbi.1000591","volume":"5","author":"A Mitsos","year":"2009","unstructured":"Mitsos A, Melas IN, Siminelakis P, Chairakaki AD, Saez-Rodriguez J, Alexopoulos LG. Identifying drug effects via pathway alterations using an integer linear programming optimization formulation on phosphoproteomic data. PLoS Comput Biol. 2009;5(12):e1000591.","journal-title":"PLoS Comput Biol"},{"issue":"5","key":"234_CR27","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, M\u00f8ller R, et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020;181(5):1036\u201345 e9.","journal-title":"Cell"},{"key":"234_CR28","doi-asserted-by":"crossref","unstructured":"Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience trends. 2020;14:72-73.","DOI":"10.5582\/bst.2020.01047"},{"issue":"1","key":"234_CR29","first-page":"1","volume":"6","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2. Cell Discovery. 2020;6(1):1\u201318.","journal-title":"Cell Discovery"},{"issue":"4","key":"234_CR30","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.4049\/jimmunol.169.4.2026","volume":"169","author":"N Tsuboi","year":"2002","unstructured":"Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, Nagai Y, et al. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol. 2002;169(4):2026\u201333.","journal-title":"J Immunol."},{"issue":"2","key":"234_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cyto.2015.03.001","volume":"74","author":"DJ Perkins","year":"2015","unstructured":"Perkins DJ, Vogel SN. Space and time: New considerations about the relationship between Toll-like receptors (TLRs) and type I interferons (IFNs). Cytokine. 2015;74(2):171\u20134.","journal-title":"Cytokine"},{"key":"234_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000289199","volume":"11","author":"A Yarilina","year":"2010","unstructured":"Yarilina A, Ivashkiv LB. Type I interferon: a new player in TNF signaling. Curr Dir Autoimmun. 2010;11:94\u2013104.","journal-title":"Curr Dir Autoimmun"},{"key":"234_CR33","doi-asserted-by":"crossref","unstructured":"Gritti G, Raimondi F, Ripamonti D, Riva I, Landi F, Alborghetti L, et al. IL-6 signalling pathway inactivation with siltuximab in patients with COVID-19 respiratory failure: an observational cohort study. medRxiv. 2020:2020.04.01.20048561.","DOI":"10.1101\/2020.04.01.20048561"},{"key":"234_CR34","doi-asserted-by":"publisher","unstructured":"Mercatelli D, Holding AN, Giorgi FM. Web tools to fight pandemics: the COVID-19 experience. Brief Bioinform. 2020:bbaa261. https:\/\/doi.org\/10.1093\/bib\/bbaa261. Epub ahead of print.","DOI":"10.1093\/bib\/bbaa261"}],"container-title":["BioData Mining"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-021-00234-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13040-021-00234-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-021-00234-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T01:04:28Z","timestamp":1611191068000},"score":1,"resource":{"primary":{"URL":"https:\/\/biodatamining.biomedcentral.com\/articles\/10.1186\/s13040-021-00234-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["234"],"URL":"https:\/\/doi.org\/10.1186\/s13040-021-00234-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-47964\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-47964\/v1","asserted-by":"object"}]},"ISSN":["1756-0381"],"issn-type":[{"value":"1756-0381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,21]]},"assertion":[{"value":"21 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}